ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.848,77
-0,34%
S&P 500
5.974,07
0,73%
Dow Jones
42.906,95
0,16%
Euro vs US Dollar
1,04056
-0,26%
Bitcoin
94.006,52
-1,16%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Standard BioTools Inc (LAB)

  7. Standard BioTools Inc (LAB) News

LAB

Standard BioTools (LAB)

Standard BioTools Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:LAB
DatumZeitQuelleÜberschriftSymbolFirma
20/12/202422h14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABStandard BioTools Inc
19/12/202414h00GlobeNewswire Inc.Standard BioTools to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:LABStandard BioTools Inc
22/11/202402h55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
14/11/202421h32Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:LABStandard BioTools Inc
12/11/202422h13Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LABStandard BioTools Inc
07/11/202414h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABStandard BioTools Inc
07/11/202414h00GlobeNewswire Inc.Standard BioTools Appoints Alex Kim as Chief Financial OfficerNASDAQ:LABStandard BioTools Inc
06/11/202423h17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LABStandard BioTools Inc
31/10/202413h01GlobeNewswire Inc.Standard BioTools to Participate in Upcoming Investor ConferencesNASDAQ:LABStandard BioTools Inc
30/10/202421h17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABStandard BioTools Inc
30/10/202421h01GlobeNewswire Inc.Standard BioTools Reports Third Quarter 2024 Financial ResultsNASDAQ:LABStandard BioTools Inc
24/10/202420h02Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:LABStandard BioTools Inc
21/10/202422h26Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:LABStandard BioTools Inc
16/10/202414h00GlobeNewswire Inc.Standard BioTools Announces Conference Call and Webcast for Third Quarter 2024 Financial Results on October 30, 2024NASDAQ:LABStandard BioTools Inc
24/09/202414h00GlobeNewswire Inc.Standard BioTools Achieves New Record of the Most Protein Measurements on the Most Sample Types with Expansion of the SomaScan® 11K PlatformNASDAQ:LABStandard BioTools Inc
18/09/202414h00GlobeNewswire Inc.Standard BioTools proteomics profiling reveals unique biomarkers and insights into nonalcoholic steatohepatitis (NASH)NASDAQ:LABStandard BioTools Inc
09/09/202421h19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LABStandard BioTools Inc
06/09/202400h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
05/09/202423h59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
05/09/202422h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABStandard BioTools Inc
03/09/202423h49Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
30/08/202422h08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABStandard BioTools Inc
30/08/202402h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
27/08/202402h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
26/08/202414h00GlobeNewswire Inc.Standard BioTools to Present at the Morgan Stanley 22nd Annual Global Healthcare ConferenceNASDAQ:LABStandard BioTools Inc
22/08/202402h47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
19/08/202423h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
17/08/202401h52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
15/08/202402h54Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:LABStandard BioTools Inc
14/08/202402h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
 Showing the most relevant articles for your search:NASDAQ:LAB

Kürzlich von Ihnen besucht

BIT
F38716
Vontobel Financial Produ...
NASDAQ
LCA
Landcadia Holdings IV
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten